aspirin has been researched along with fondaparinux in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (30.00) | 29.6817 |
| 2010's | 26 (65.00) | 24.3611 |
| 2020's | 2 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burggraaf, J; Cohen, AF; de Greef, R; Duvauchelle, T; Faaij, RA; Ollier, C; Santoni, A; Schoemaker, RC; van Haard, PM | 1 |
| Kearon, C | 1 |
| Bergqvist, D; Colwell, CW; Geerts, WH; Heit, JA; Lassen, MR; Pineo, GF; Ray, JG | 1 |
| Stiefelhagen, P | 1 |
| Gogarten, W | 1 |
| Go, G; Gonzalez Della Valle, A; Lyman, S; Salvati, EA; Sharrock, NE | 1 |
| Cockbain, AJ; El Masry, MA; Katonis, P; Lindner, T; Schizas, C; Tsiridis, E | 1 |
| Becker, RC; Cannon, CP; Goodman, SG; Gutterman, D; Guyatt, GH; Harrington, RA; Lincoff, AM; Popma, JJ; Steg, G | 1 |
| Fishmann, A | 1 |
| Boyd, HS | 1 |
| Gibson, CM; Hollander, JE; Pollack, CV | 1 |
| Brotman, DJ; Grant, PJ; Jaffer, AK | 1 |
| Auerbach, AD; Bozic, KJ; Lindenauer, PK; Maselli, JH; Pekow, PS; Vail, TP | 1 |
| Butwick, AJ; Carvalho, B | 1 |
| Cohen, AT; Nandini, B; Ota, S; Wills, JO | 1 |
| Dager, WE | 1 |
| Aïssaoui, N; Danchin, N | 1 |
| Pellegrini, VD | 1 |
| Haslauer, M; Nagler, M; Wuillemin, WA | 1 |
| Donohoe, CL; Niall, DM; Sayana, MK; Thakral, R | 1 |
| Basra, SS; Lakkis, NM; Tsai, P | 1 |
| Callahan, S; Goldsberry, A; Kim, G; Yoo, S | 1 |
| Giannubilo, SR; Tranquilli, AL | 1 |
| Bates, P; Culpan, P; El-Daly, I; Reidy, J | 1 |
| Fiaccadori, E; Maggiore, U; Regolisti, G | 1 |
| Dugdale, M; Fabian, TC; Gordon, JL; Lee, MD | 1 |
| Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V | 1 |
| Gupta, K; Singh, D; Vacek, JL | 1 |
| Kimber-Trojnar, Z; Leszczynska-Gorzelak, B; Mierzynski, R; Oleszczuk, J; Poniedzialek-Czajkowska, E | 1 |
| Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L | 1 |
| Borzi, M; Caporale, R; Casolo, G; Colivicchi, F; Di Bartolomeo, R; Formigli, D; Geraci, G; Gerometta, P; Gulizia, MM; Ledda, A; Menozzi, A; Musumeci, G; Romeo, F; Scherillo, M; Tarantini, G | 1 |
| Bang, SM; Lee, J; Lee, JO; Lee, JY; Yhim, HY | 1 |
| Bini, SA; Cafri, G; Cheetham, CT; Chen, Y; Gould, MK; Khatod, M; Paxton, EW; Sluggett, J | 1 |
| Cavallari, I; Patti, G | 1 |
| Azboy, I; Groff, H; Parvizi, J | 1 |
| Bawa, H; Dirschl, DR; Luu, HH; Weick, JW | 1 |
| Gottschalk, MB; Pour, AE; Roberson, JR; Runner, RP; Staley, CA | 1 |
| Bostrom, MP; Richardson, SS; Schairer, WW; Sculco, PK | 1 |
| Amoroso, G; de Winter, RJ; Fagel, ND; Herrman, JP; Oosterwerff, EFJ; Patterson, MS; Riezebos, RK; Slagboom, T; Tijssen, JGP; van der Schaaf, RJ; Verheugt, FWA; Vink, MA; Vos, NS | 1 |
| Chaturvedi, S; Hussain, H; McCrae, KR; Roberts, JC; Tarantino, MD | 1 |
21 review(s) available for aspirin and fondaparinux
| Article | Year |
|---|---|
Duration of venous thromboembolism prophylaxis after surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Drug Administration Schedule; Fondaparinux; Hemorrhage; Heparin; Humans; Polysaccharides; Postoperative Complications; Prevalence; Radiography; Risk Factors; Time Factors; Venous Thrombosis; Warfarin | 2003 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Assessment; Venous Thrombosis; Vitamin K | 2004 |
[Patient with antithrombotic medication. Which do bleedings or preoperative?].
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atherosclerosis; Atrial Fibrillation; Blood Coagulation Tests; Cerebral Infarction; Drug Therapy, Combination; Female; Fibrinolytic Agents; Fondaparinux; Heart Valve Prosthesis; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Polysaccharides; Preoperative Care; Prevalence; Primary Prevention; Pulmonary Embolism; Risk Factors; Sex Factors; Stroke; Time Factors; Venous Thrombosis | 2006 |
The influence of new antithrombotic drugs on regional anesthesia.
Topics: Adenosine Diphosphate; Anesthesia, Conduction; Anesthesia, Epidural; Aspirin; Cardiac Surgical Procedures; Clinical Trials as Topic; Drug Administration Schedule; Female; Fibrinolytic Agents; Fondaparinux; Hematoma, Epidural, Spinal; Heparin, Low-Molecular-Weight; Humans; Nerve Block; Pain Measurement; Pain, Postoperative; Plant Preparations; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Practice Guidelines as Topic; Prevalence; Risk Assessment; Risk Factors | 2006 |
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Topics: Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Azetidines; Benzylamines; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin | 2008 |
The effect of anticoagulant pharmacotherapy on fracture healing.
Topics: Animals; Anticoagulants; Aspirin; Bone and Bones; Bone Remodeling; Disease Models, Animal; Fondaparinux; Fracture Healing; Heparin; Humans; Polysaccharides; Warfarin | 2008 |
Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Emergency Service, Hospital; Enoxaparin; Fondaparinux; Health Services Accessibility; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Polysaccharides; Recombinant Proteins; Ticlopidine; Triage; United States | 2009 |
Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Anticoagulants; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Fondaparinux; Guidelines as Topic; Hematoma, Epidural, Spinal; Heparin; Hirudins; Humans; Polysaccharides; Pregnancy; Ticlopidine; Warfarin | 2010 |
VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Topics: Anticoagulants; Aspirin; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Neoplasms; Polysaccharides; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin | 2010 |
Issues in assessing and reducing the risk for venous thromboembolism.
Topics: Anticoagulants; Aspirin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Polysaccharides; Risk Assessment; Risk Factors; Risk Reduction Behavior; Thrombocytopenia; Ultrasonography; United States; Venous Thromboembolism; Warfarin | 2010 |
Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy.
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Disease Management; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine | 2010 |
Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Lower Extremity; Polysaccharides; Practice Guidelines as Topic; Pulmonary Embolism; Venous Thrombosis | 2011 |
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine; Uremia | 2011 |
The management of antithrombotic medication in skin surgery.
Topics: Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Dermatologic Surgical Procedures; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Risk Assessment; Rivaroxaban; Thienopyridines; Thiophenes; Vitamin K; Warfarin | 2012 |
Thromboprophylaxis in patients with pelvic and acetabular fractures: A short review and recommendations.
Topics: Acetabulum; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Fondaparinux; Fractures, Bone; Heparin; Humans; Mass Screening; Morpholines; Multiple Trauma; Pelvis; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Vena Cava Filters; Venous Thromboembolism | 2013 |
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.
Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondaparinux; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Platelet Transfusion; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Ticlopidine; Warfarin | 2013 |
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2014 |
Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2014 |
Anticoagulant therapy in pregnant patients with metabolic syndrome: a review.
Topics: Animals; Anticoagulants; Aspirin; Female; Fondaparinux; Heparin; Humans; Metabolic Syndrome; Polysaccharides; Pregnancy; Venous Thromboembolism; Warfarin | 2014 |
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin | 2014 |
Clinical effects with inhibition of multiple coagulative pathways in patients admitted for acute coronary syndrome.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation Factors; Fondaparinux; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Recombinant Proteins | 2018 |
2 trial(s) available for aspirin and fondaparinux
| Article | Year |
|---|---|
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
Topics: Adult; Aspirin; Bleeding Time; Cross-Over Studies; Double-Blind Method; Drug Interactions; Fibrinolytic Agents; Fondaparinux; Humans; Male; Middle Aged; Partial Thromboplastin Time; Piroxicam; Platelet Aggregation Inhibitors; Polysaccharides | 2002 |
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
Topics: Aged; Area Under Curve; Aspirin; Cause of Death; Combined Modality Therapy; Coronary Angiography; Creatine Kinase, MB Form; Early Termination of Clinical Trials; Factor Xa Inhibitors; Female; Fondaparinux; Humans; Male; Medical Futility; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Ticagrelor; Time Factors | 2021 |
17 other study(ies) available for aspirin and fondaparinux
| Article | Year |
|---|---|
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Electrocardiography; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Polysaccharides; Risk Assessment; Risk Factors; Ticlopidine; Tirofiban; Tyrosine | 2008 |
VTE prevention in major orthopedic surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Fondaparinux; Humans; Orthopedics; Platelet Aggregation Inhibitors; Polysaccharides; Risk Factors; Venous Thromboembolism | 2008 |
VTE prevention in major orthopedic surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Risk Assessment; Risk Reduction Behavior; Venous Thromboembolism; Warfarin | 2008 |
Perioperative anticoagulant management.
Topics: Adult; Aged; Anticoagulants; Aspirin; Drug Administration Schedule; Drug Synergism; Female; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Perioperative Care; Polysaccharides; Risk Factors; Vena Cava Filters; Venous Thromboembolism; Warfarin | 2009 |
Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Female; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polysaccharides; Postoperative Complications; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome; Venous Thromboembolism; Warfarin | 2010 |
DVT prophylaxis: better living through chemistry: affirms.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Patient Readmission; Platelet Aggregation Inhibitors; Polysaccharides; Postoperative Hemorrhage; Practice Guidelines as Topic; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2010 |
Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve.
Topics: Anticoagulants; Aortic Valve Stenosis; Aspirin; Drug Therapy, Combination; Fondaparinux; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Polysaccharides; Postoperative Complications; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome | 2011 |
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
Topics: Anticoagulants; Aspirin; Bone Density; Breast Feeding; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Polysaccharides; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Thrombophilia; Warfarin | 2012 |
Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Humans; Kidney Failure, Chronic; Polysaccharides; Renal Dialysis; Thromboembolism; Vascular Calcification; Vitamin K; Warfarin | 2013 |
[ANMCO/SIC/SICI-GISE/SICCH Consensus document: Clinical approach to pharmacological pretreatment for patients undergoing myocardial revascularization].
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fondaparinux; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Myocardial Revascularization; Platelet Aggregation Inhibitors; Polysaccharides; Preoperative Care; Ticlopidine; Treatment Outcome | 2016 |
Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Erythrocyte Transfusion; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Polysaccharides; Postoperative Complications; Postoperative Hemorrhage; Republic of Korea; Risk Factors; Rivaroxaban; Venous Thromboembolism | 2017 |
Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Polysaccharides; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2017 |
Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Conflict of Interest; Dabigatran; Enoxaparin; Female; Fondaparinux; Health Care Sector; Hemorrhage; Humans; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Venous Thromboembolism; Warfarin | 2018 |
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Decision-Making; Dabigatran; Databases, Factual; Enoxaparin; Female; Fondaparinux; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin | 2018 |
Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Databases, Factual; Enoxaparin; Female; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Orthopedic Procedures; Orthopedics; Practice Patterns, Physicians'; Risk Factors; Rivaroxaban; United States; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2019 |
Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Databases, Factual; Factor Xa Inhibitors; Female; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Venous Thromboembolism; Warfarin | 2019 |
Eculizumab for refractory thrombosis in antiphospholipid syndrome.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antiphospholipid Syndrome; Aspirin; Clopidogrel; Female; Fondaparinux; Humans; Hydroxychloroquine; Thrombosis | 2022 |